Get started
Author

Maria I. Syrovenko

Observed names: M. I. Syrovenko, M.I. Syrovenko, Сыровенко Мария Ильинична
Observed institution: Omsk State Medical University
ORCID: 0000-0001-6300-367X
Observed ORCID: 0000-0001-6300-367X
OpenAlex ID: A5049791768
Non-alcoholic fatty liver disease and women's health
2023 · M.A. Livzan, M.I. Syrovenko, et al. · Russian Medical Inquiry · 13
PDF
Liver fibrosis in nonalcoholic fatty liver disease: the role of adipokines and noninvasive assessment of the intestinal barrier
2023 · T.S. Krolevets, M.A. Livzan, et al. · Russian Journal of Evidence-Based Gastroenterology · 7
Pathogenic aspects of the comorbid course of non-alcoholic fatty liver disease and cholelithiasis: a review and the authors’ results
2022 · T.S. Krolevets, M.A. Livzan, et al. · Russian Medical Inquiry · 4
PDF
Lifestyle of patients with non-alcoholic fatty liver disease: assessment of dietary habits and physical activity
2023 · T.S. Krolevets, M.I. Syrovenko, et al. · Russian Journal of Evidence-Based Gastroenterology · 3
Prediction model for the development of liver fibrosis in patients with metabolic dysfunction–associated steatotic liver disease
2024 · T.S. Krolevets, M.A. Livzan, et al. · Russian Medical Inquiry · 2
Structure of Cardiovascular Comorbidity in Patients with Non-Alcoholic Fatty Liver Disease
2024 · M.I. Syrovenko, M.A. Livzan, et al. · Effective Pharmacotherapy · 1
Role of adipokines in the formation of metabolic disorders in conditions of metabolic-associated fatty liver disease (MAFLD)
2024 · M. A. Livzan, T. S. Krolevets, et al. · Экспериментальная и клиническая гастроэнтерология · 1
PDF
Non-alcoholic fatty liver disease and the risk of malignant tumors
2023 · M. A. Livzan, M. I. Syrovenko, et al. · Meditsinskiy sovet = Medical Council · 1
PDF
Liver Fibrosis in Some Patients with Non-Alcoholic Fatty Liver Disease: from Diagnosis to Prognosis
2024 · Tatyana S. Krolevets, Maria A. Livzan, et al. · Annals of the Russian academy of medical sciences
PDF
Mechanisms of high cardiovascular risk in patients with nonalcoholic fatty liver disease
2024 · Maria I. Syrovenko, Tatyana S. Krolevets, et al. · Consilium Medicum
PDF
The role of short-chain fatty acids in the progression of non-alcoholic fatty liver disease
2024 · T. S. Krolevets, M. A. Livzan, et al. · Meditsinskiy sovet = Medical Council
Роль короткоцепочечных жирных кислот в прогрессировании неалкогольной жировой болезни печени
· Кролевец Татьяна Сергеевна, Ливзан Мария Анатольевна, et al. · CyberLeninK (CyberLeninka)
Неалкогольная жировая болезнь печени и риск злокачественных новообразований
· Ливзан Мария Анатольевна, Сыровенко Мария Ильинична, et al. · CyberLeninK (CyberLeninka)
Фиброз печени у больного неалкогольной жировой болезнью печени: от диагностики к прогнозу
· Кролевец Татьяна Сергеевна, Ливзан Мария Анатольевна, et al. · CyberLeninK (CyberLeninka)
Works count: 16
Citation count: 32
H-index: 3
I10-index: 1
Year
Topic
Type